However, nivolumab showed promising clinical and radiographic responses in a small case series of patients with relapsed/refractory primary CNS lymphoma (PCNSL) and primary testicular lymphoma (PTL), both of which frequently harbor 9p24.1/PD-L1/PD-L2 alterations. Here, PDCD1LG2 is linked to primary central nervous system lymphoma.